Tilray Brands (TLRY) Net Equity Issued and Repurchased (2020 - 2025)
Tilray Brands (TLRY) posted Net Equity Issued and Repurchased of $50.6 million for Q4 2025, up 124.83% on a QoQ basis from $22.5 million in Q3 2025.
Tilray Brands (TLRY) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Tilray Brands' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $50.6 million for Q4 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $50.6 million in Q4 2025, while the trailing twelve-month figure through Feb 2026 was $94.5 million (changed 0.2% YoY) and the FY2025 annual result came in at $161.2 million, up 1770.15% from the prior year.
- Net Equity Issued and Repurchased was $50.6 million for Q4 2025 at Tilray Brands, up from $22.5 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $262.5 million in Q2 2022 and bottomed at $21.4 million in Q2 2025.
- A 3-year average of $83.0 million and a median of $50.6 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 66.16% in 2025, while the deepest fall reached 66.16% in 2025.
- Tilray Brands' Net Equity Issued and Repurchased stood at $129.6 million in 2022, then tumbled by 48.71% to $66.5 million in 2024, then dropped by 23.93% to $50.6 million in 2025.
- Business Quant data shows TLRY's Net Equity Issued and Repurchased at $50.6 million in Q4 2025, $22.5 million in Q3 2025, and $21.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 50.57 Mn |
| Nov 30, 2025 | 50.57 Mn |
| Aug 31, 2025 | 22.49 Mn |
| Aug 31, 2025 | 22.49 Mn |
| May 31, 2025 | 21.45 Mn |
| May 31, 2025 | 21.45 Mn |
| Feb 28, 2025 | 28.22 Mn |
| Feb 28, 2025 | 28.22 Mn |
| Aug 31, 2024 | 66.47 Mn |
| Aug 31, 2024 | 66.47 Mn |
| Aug 31, 2022 | 129.59 Mn |
| Aug 31, 2022 | 129.59 Mn |
| May 31, 2022 | 262.51 Mn |
| May 31, 2022 | 262.51 Mn |
| Nov 30, 2020 | 102.82 Mn |
| Nov 30, 2020 | 102.82 Mn |
| Aug 31, 2020 | -261,000.00 |
| Aug 31, 2020 | -261,000.00 |
| Mar 31, 2020 | 85.47 Mn |
| Mar 31, 2020 | 85.47 Mn |